Omri Erez

492 total citations
13 papers, 324 citations indexed

About

Omri Erez is a scholar working on Molecular Biology, Biochemistry and Plant Science. According to data from OpenAlex, Omri Erez has authored 13 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Biochemistry and 3 papers in Plant Science. Recurrent topics in Omri Erez's work include Polyamine Metabolism and Applications (5 papers), Fungal and yeast genetics research (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Omri Erez is often cited by papers focused on Polyamine Metabolism and Applications (5 papers), Fungal and yeast genetics research (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Omri Erez collaborates with scholars based in Israel, Germany and France. Omri Erez's co-authors include Chaim Kahana, Ziv Porat, Daniel Taglicht, Yuval Reiss, Alona Keren‐Paz, Z. Bercovich, Shmuel Tuvia, Iris Alchanati, Haim Barr and Itzchak Angel and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Omri Erez

11 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omri Erez Israel 8 279 62 58 37 32 13 324
Markus Fido Austria 5 336 1.2× 135 2.2× 105 1.8× 41 1.1× 21 0.7× 7 413
Masaki Makise Japan 14 479 1.7× 116 1.9× 21 0.4× 23 0.6× 36 1.1× 33 560
Margaret K. Shirra United States 12 548 2.0× 71 1.1× 36 0.6× 85 2.3× 17 0.5× 14 604
Dina Darwis Singapore 9 370 1.3× 38 0.6× 42 0.7× 31 0.8× 13 0.4× 9 451
Kojiro Takeda Japan 12 452 1.6× 151 2.4× 17 0.3× 69 1.9× 18 0.6× 19 526
Ayelén González Montoro Germany 11 286 1.0× 154 2.5× 30 0.5× 25 0.7× 6 0.2× 18 359
Kyoung‐Soo Choi United States 8 257 0.9× 24 0.4× 32 0.6× 30 0.8× 8 0.3× 10 345
Aristeidis Sfakianos United Kingdom 8 262 0.9× 41 0.7× 22 0.4× 14 0.4× 14 0.4× 9 297
Tanya A. Wahl United States 6 248 0.9× 115 1.9× 34 0.6× 51 1.4× 9 0.3× 10 355
Ruth Nebauer Austria 7 292 1.0× 85 1.4× 54 0.9× 30 0.8× 14 0.4× 7 442

Countries citing papers authored by Omri Erez

Since Specialization
Citations

This map shows the geographic impact of Omri Erez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omri Erez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omri Erez more than expected).

Fields of papers citing papers by Omri Erez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omri Erez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omri Erez. The network helps show where Omri Erez may publish in the future.

Co-authorship network of co-authors of Omri Erez

This figure shows the co-authorship network connecting the top 25 collaborators of Omri Erez. A scholar is included among the top collaborators of Omri Erez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omri Erez. Omri Erez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Arad, Gali, et al.. (2023). Abstract 5410: Predictive biomarker discovery method to bridge the gap between preclinical disease model dose-response and clinical trials. Cancer Research. 83(7_Supplement). 5410–5410. 1 indexed citations
2.
Perets, Ruth, Meredith McKean, Andreas Goutopoulos, et al.. (2022). Phase 1 first-in-human trial of MTB-9655, the first oral inhibitor of ACSS2, in patients with advanced solid tumors.. Journal of Clinical Oncology. 40(16_suppl). e20609–e20609. 6 indexed citations
3.
Goutopoulos, Andreas, et al.. (2022). Abstract 2326: Preclinical characterization of MTB-9655, a first-in-class, clinical stage ACSS2 inhibitor. Cancer Research. 82(12_Supplement). 2326–2326.
4.
Goutopoulos, Andreas, Omri Erez, Iris Alchanati, et al.. (2020). Abstract LB-295: Discovery of potent selective oral ACSS2 inhibitors for the treatment of acetate avid tumors. Cancer Research. 80(16_Supplement). LB–295.
5.
Votteler, Jörg, Elena Iavnilovitch, Orit Fingrut, et al.. (2009). Exploring the functional interaction between POSH and ALIX and the relevance to HIV-1 release. BMC Biochemistry. 10(1). 12–12. 19 indexed citations
6.
Alchanati, Iris, Galit Cohen, Haim Barr, et al.. (2009). The E3 Ubiquitin-Ligase Bmi1/Ring1A Controls the Proteasomal Degradation of Top2α Cleavage Complex – A Potentially New Drug Target. PLoS ONE. 4(12). e8104–e8104. 71 indexed citations
7.
Tuvia, Shmuel, Daniel Taglicht, Omri Erez, et al.. (2007). The ubiquitin E3 ligase POSH regulates calcium homeostasis through spatial control of Herp. The Journal of Cell Biology. 177(1). 51–61. 39 indexed citations
8.
Porat, Ziv, Omri Erez, & Chaim Kahana. (2006). Cellular localization and phosphorylation of Hrb1p is independent of Sky1p. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1763(2). 207–213. 3 indexed citations
9.
Keren‐Paz, Alona, et al.. (2006). Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions. Oncogene. 25(37). 5163–5172. 59 indexed citations
10.
Porat, Ziv, et al.. (2005). Mechanism of polyamine tolerance in yeast: novel regulators and insights. Cellular and Molecular Life Sciences. 62(24). 3106–3116. 29 indexed citations
11.
Erez, Omri. (2002). Putrescine Activates Oxidative Stress Dependent Apoptotic Death in Ornithine Decarboxylase Overproducing Mouse Myeloma Cells. Experimental Cell Research. 281(1). 148–156. 28 indexed citations
12.
Erez, Omri & Chaim Kahana. (2002). Deletions of SKY1 or PTK2 in the Saccharomyces cerevisiaetrk1Δtrk2Δ mutant cells exert dual effect on ion homeostasis. Biochemical and Biophysical Research Communications. 295(5). 1142–1149. 27 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markus Fido Breakdown of academic impact, for papers by Masaki Makise Breakdown of academic impact, for papers by Margaret K. Shirra Breakdown of academic impact, for papers by Dina Darwis Breakdown of academic impact, for papers by Kojiro Takeda Breakdown of academic impact, for papers by Ayelén González Montoro Breakdown of academic impact, for papers by Kyoung‐Soo Choi Breakdown of academic impact, for papers by Aristeidis Sfakianos Breakdown of academic impact, for papers by Tanya A. Wahl Breakdown of academic impact, for papers by Ruth Nebauer
Rankless by CCL
2026